293 related articles for article (PubMed ID: 7559308)
1. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.
Lombroso PJ; Scahill L; King RA; Lynch KA; Chappell PB; Peterson BS; McDougle CJ; Leckman JF
J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1147-52. PubMed ID: 7559308
[TBL] [Abstract][Full Text] [Related]
2. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study.
Cubo E; Fernández Jaén A; Moreno C; Anaya B; González M; Kompoliti K
Clin Ther; 2008 Jan; 30(1):182-9. PubMed ID: 18343255
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of risperidone for children and adolescents with chronic tic or tourette disorders in Korea.
Kim BN; Lee CB; Hwang JW; Shin MS; Cho SC
J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):318-24. PubMed ID: 15910216
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
[TBL] [Abstract][Full Text] [Related]
5. Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial.
Gilbert DL; Batterson JR; Sethuraman G; Sallee FR
J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):206-14. PubMed ID: 14726728
[TBL] [Abstract][Full Text] [Related]
6. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome.
Gaffney GR; Perry PJ; Lund BC; Bever-Stille KA; Arndt S; Kuperman S
J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):330-6. PubMed ID: 11886028
[TBL] [Abstract][Full Text] [Related]
7. Risperidone-induced obsessive-compulsive symptoms in two children.
Diler RS; Yolga A; Avci A; Scahill L
J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S89-92. PubMed ID: 12880504
[TBL] [Abstract][Full Text] [Related]
8. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder.
Diniz JB; Rosario-Campos MC; Hounie AG; Curi M; Shavitt RG; Lopes AC; Miguel EC
J Psychiatr Res; 2006 Sep; 40(6):487-93. PubMed ID: 16289552
[TBL] [Abstract][Full Text] [Related]
9. An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
Boon-yasidhi V; Kim YS; Scahill L
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S156-62. PubMed ID: 16856436
[TBL] [Abstract][Full Text] [Related]
10. Determinants of quality of life in children with Gilles de la Tourette syndrome.
Bernard BA; Stebbins GT; Siegel S; Schultz TM; Hays C; Morrissey MJ; Leurgans S; Goetz CG
Mov Disord; 2009 May; 24(7):1070-3. PubMed ID: 19306279
[TBL] [Abstract][Full Text] [Related]
11. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome.
Bloch MH; Peterson BS; Scahill L; Otka J; Katsovich L; Zhang H; Leckman JF
Arch Pediatr Adolesc Med; 2006 Jan; 160(1):65-9. PubMed ID: 16389213
[TBL] [Abstract][Full Text] [Related]
12. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.
Allen AJ; Kurlan RM; Gilbert DL; Coffey BJ; Linder SL; Lewis DW; Winner PK; Dunn DW; Dure LS; Sallee FR; Milton DR; Mintz MI; Ricardi RK; Erenberg G; Layton LL; Feldman PD; Kelsey DK; Spencer TJ
Neurology; 2005 Dec; 65(12):1941-9. PubMed ID: 16380617
[TBL] [Abstract][Full Text] [Related]
13. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.
Sallee FR; Kurlan R; Goetz CG; Singer H; Scahill L; Law G; Dittman VM; Chappell PB
J Am Acad Child Adolesc Psychiatry; 2000 Mar; 39(3):292-9. PubMed ID: 10714048
[TBL] [Abstract][Full Text] [Related]
14. The relationship between tic disorders and Tourette's syndrome revisited.
Spencer T; Biederman J; Harding M; Wilens T; Faraone S
J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1133-9. PubMed ID: 7559306
[TBL] [Abstract][Full Text] [Related]
15. Risperidone as a treatment for Tourette's syndrome.
Bruun RD; Budman CL
J Clin Psychiatry; 1996 Jan; 57(1):29-31. PubMed ID: 8543544
[TBL] [Abstract][Full Text] [Related]
16. Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide.
Lipinski JF; Sallee FR; Jackson C; Sethuraman G
Mov Disord; 1997 May; 12(3):402-7. PubMed ID: 9159736
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
[TBL] [Abstract][Full Text] [Related]
18. Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.
McDougle CJ; Holmes JP; Bronson MR; Anderson GM; Volkmar FR; Price LH; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):685-93. PubMed ID: 9136504
[TBL] [Abstract][Full Text] [Related]
19. Life events and Tourette syndrome.
Steinberg T; Shmuel-Baruch S; Horesh N; Apter A
Compr Psychiatry; 2013 Jul; 54(5):467-73. PubMed ID: 23219489
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience.
Riddle MA; Hardin MT; King R; Scahill L; Woolston JL
J Am Acad Child Adolesc Psychiatry; 1990 Jan; 29(1):45-8. PubMed ID: 2295577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
